Deepika Pakianathan's Net Worth

$60 Million

Who is Deepika Pakianathan?

Deepika Pakianathan has an estimated net worth of $60 Million. This is based on reported shares across multiple companies, which include TRANS1 INC, ALDER BIOPHARMACEUTICALS INC, Alexza Pharmaceuticals Inc., TriVascular Technologies, Inc., TANDEM DIABETES CARE INC, Senseonics Holdings, Inc., Theravance Biopharma, Inc., PARDES BIOSCIENCES, INC., Karyopharm Therapeutics Inc., FS Development Corp., Calithera Biosciences, Inc., and OncoMed Pharmaceuticals Inc.

SEC CIK

Deepika Pakianathan's CIK is 0001270734

Past Insider Trading and Trends

2014 was Deepika Pakianathan's most active year for acquiring shares with 47 total transactions. Deepika Pakianathan's most active month to acquire stocks was the month of April. 2014 was Deepika Pakianathan's most active year for disposing of shares, totalling 14 transactions. Deepika Pakianathan's most active month to dispose stocks was the month of May. 2014 saw Deepika Pakianathan paying a total of $29,995,458.13 for 18,101,795 shares, this is the most they've acquired in one year. In 2022 Deepika Pakianathan cashed out on 538,784 shares for a total of $3,434,798.40, their largest year based on trade value.